Australia - English - Department of Health (Therapeutic Goods Administration)

catalent australia pty ltd - calcium citrate,chromic chloride hexahydrate,cupric sulfate,ferrous sulfate,magnesium citrate,manganese sulfate monohydrate,potassium sulfate,selenomethionine,sodium molybdate dihydrate,zinc gluconate -

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - ascorbic acid,biotin,calcium carbonate,calcium hydrogen phosphate dihydrate,calcium pantothenate,chromic chloride hexahydrate,colecalciferol,cupric oxide,cyanocobalamin,d-alpha-tocopheryl acetate,ferrous fumarate,folic acid,heavy magnesium oxide,manganese sulfate monohydrate,nicotinamide,potassium citrate,potassium iodide,pyridoxine hydrochloride,retinol acetate,riboflavin,selenomethionine,thiamine hydrochloride,zinc sulfate monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - ascorbic acid,arthrospira maxima,biotin,calcium carbonate,calcium pantothenate,chromic chloride hexahydrate,colecalciferol,cupric oxide,cyanocobalamin,dl-alpha-tocopheryl acetate,ferrous fumarate,folic acid,heavy magnesium oxide,manganese sulfate monohydrate,nicotinamide,potassium citrate,potassium iodide,pyridoxine hydrochloride,retinol acetate,riboflavin,reynoutria japonica,thiamine nitrate,zinc sulfate monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - ascorbic acid,biotin,calcium carbonate,calcium pantothenate,chromic chloride hexahydrate,colecalciferol,cupric oxide,cyanocobalamin,dl-alpha-tocopheryl acetate,ferrous fumarate,folic acid,heavy magnesium oxide,manganese sulfate monohydrate,nicotinamide,potassium citrate,potassium iodide,pyridoxine hydrochloride,retinol acetate,riboflavin,thiamine nitrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - ascorbic acid,biotin,calcium carbonate,calcium pantothenate,chromic chloride hexahydrate,colecalciferol,cupric oxide,cyanocobalamin,camellia sinensis,dl-alpha-tocopheryl acetate,ferrous fumarate,folic acid,heavy magnesium oxide,manganese sulfate monohydrate,nicotinamide,potassium citrate,potassium iodide,pyridoxine hydrochloride,riboflavin,thiamine nitrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - ascorbic acid,biotin,calcium carbonate,calcium pantothenate,chromic chloride hexahydrate,colecalciferol,cupric oxide,cyanocobalamin,camellia sinensis,dl-alpha-tocopheryl acetate,ferrous fumarate,folic acid,heavy magnesium oxide,manganese sulfate monohydrate,nicotinamide,potassium citrate,potassium iodide,pyridoxine hydrochloride,riboflavin,thiamine nitrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

natural bio pty limited - ascorbic acid,biotin,borax,calcium hydrogen phosphate,chromic chloride hexahydrate,colecalciferol,calcium carbonate,calcium pantothenate,cupric oxide,cyanocobalamin,d-alpha-tocopheryl acetate,ferrous fumarate,folic acid,heavy magnesium oxide,manganese sulfate monohydrate,molybdenum trioxide,nicotinamide,pyridoxine hydrochloride,phytomenadione,potassium citrate,potassium iodide,retinol acetate,riboflavin,selenomethionine,thiamine hydrochloride,zinc sulfate monohydrate -

United States - English - NLM (National Library of Medicine)

nnodum pharmaceuticals - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - ferrous cation 151 mg - for the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, metabolic disease and post-surgical convalescence. hemochromatosis and hemosiderosis are contraindications to iron therapy. folic acid is contraindicated in patients with pernicious anemia (see precautions). soybean oil, lecithin, di calcium phosphate anhydrous, beeswax yellow, hydrogenated soybean oil.

United States - English - NLM (National Library of Medicine)

avkare, inc. - moexipril hydrochloride (unii: q1umg3uh45) (moexiprilat - unii:h3753190js), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - moexipril hydrochloride 7.5 mg - moexipril hydrochloride and hydrochlorothiazide tablets usp are indicated for treatment of patients with hypertension. this fixed combination is not indicated for the initial therapy of hypertension (see dosage and administration). in using moexipril hydrochloride and hydrochlorothiazide tablets usp, consideration should be given to the fact that another ace inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that moexipril hydrochloride and hydrochlorothiazide tablets usp do not have a similar risk (see warnings , neutropenia/agranulocytosis ). in addition, ace inhibitors, for which adequate data are available, cause a higher rate of angioedema in black than in nonblack patients (see warnings , angioedema ). moexipril hydrochloride and hydrochlorothiazide tablets are contraindicated in patients who are hypersensitiv

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - cevimeline hydrochloride (unii: p81q6v85np) (cevimeline - unii:k9v0cdq56e) - cevimeline hydrochloride anhydrous 30 mg - cevimeline hydrochloride is indicated for the treatment of symptoms of dry mouth in patients with sjögren’s syndrome. cevimeline hydrochloride is contraindicated in patients with uncontrolled asthma, known hypersensitivity to cevimeline, and when miosis is undesirable, e.g., in acute iritis and in narrow-angle (angle-closure) glaucoma.